Cara Therapeutics | CARA - Receita De Vendas

Preço das Ações
4.18
Mudança Diária
-0.03 -0.71%
Mensal
41.22%
Anual
-83.68%
Q2 Previsão
3.07




Vendas Alterar Data
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Assertio Holdings USD 29.2M 1.92M 2024-09
Cara Therapeutics USD 2.57M 1.11M 2025-03
Chugai Pharma JPY 321.75B 24.55B 2026-03
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
J&J USD 24.1B 500M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Pacira USD 177M 19.87M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
RedHill Biopharma USD 1.29M 722K 2024-06
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12